FDA Inspection
Biomat USA, IncorporatedBiomat USA, Incorporated – FDA Inspection, Feb 18, 2026
Record Details
This FDA Inspection record concerns Biomat USA, Incorporated, with an inspection on February 18, 2026, issued by the Denver District Office, covering biologics.
View Company Profile
ID · 7fa8d789-dfde-4933-9618-63ff88ef8f19
Inspection Facts
- Inspection number
- 1303232
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 606.100(b)(5)Accurate measurement of quantity of blood
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.170(a)Adverse Reaction - Investigations
- 21 CFR 606.60(a)Provide proper equipment to meet requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Incorporated
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2019 | Not classified | Denver District Office | |
| April 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Incorporated
- FDA Inspection 1097379 - 2019-06-19
- FDA Inspection 1049076 - 2018-04-12
- FDA Inspection 981004 - 2016-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.